Resources

This fact sheet describes PATH's technical assistance work with low- and middle-income vaccine manufacturers and the Sustaining Vaccine Manufacturing program. It provides an overview of how we work and what we do, our capabilities, our successes, and how to work with us.

This fact sheet details successes from PATH's Sustaining Vaccine Manufacturing program to improve global access to essential, high-quality, affordable vaccines. Highlighted examples include navigating and achieving WHO prequalification; keeping up with rising regulatory standards; developing fit-for-purpose vaccine technologies; finding solutions for critical supply issues; conducting landscape and capacity assessments; fostering collaboration across borders; and more.

When countries consider introducing new vaccines, immunization program cost and affordability are key questions. Data are limited on what vaccinating pregnant populations costs. To help fill this gap, PATH conducted prospective studies in collaboration with ministries of health and other partners to understand cost of delivery and introduction implications for new vaccines given in pregnancy in Bangladesh, Ghana, Kenya, Mozambique, and Nepal. The estimates will help inform policy decisions in low- and middle-income countries where maternal immunization-preventable diseases often hit hardest.Find here links to the peer-reviewed journal articles and fact sheets summarizing the research from all countries. (Materials available in English and, as applicable, in Portuguese.)

Primary health care (PHC) is recognized as the most inclusive, equitable, and cost-effective approach to enhancing people’s health and well-being, while facilitating universal access to integrated health services, positioning it as the “engine” for driving progress towards Universal Health Coverage.Integration is a key enabler for people-centered PHC, and can be defined and approached in numerous ways depending on contextual factors and needs. As countries look towards 2030 health goals and health system leaders consider how to strategically advance integrated systems and services, additional practical guidance is needed for how to prepare, design, implement, and monitor integration.This refreshed primer aims to equip policymakers, health system planners, implementers, advocates, and donors with pragmatic guidance, learnings, and tools as they advance integrated systems and services to strengthen PHC.Building from a literature review and learnings from PATH’s experience advancing integrated services and systems across varied contexts, this primer offers practical considerations and resources for approaching integration, including:an orientation and framework for approaching the type (“what”) and degree (“how”) of integration, including context-specific examples of operationalizing integration within the domains of service delivery, organizational and professional networks, and health systems.guiding principles to consider during planning and implementation.a shortlist of tools and resources to assess readiness and adoption of an integrated model, including the Readiness Assessment and Prioritization for Integration Decisions (RAPID) tool.approaches for measuring integration aligned with contextual and integration priorities—emphasizing coverage, quality, and cost—with illustrative indicators.country spotlights featuring applied integration experience in Ethiopia, India, Indonesia, Kenya, Senegal, Ukraine, and Vietnam.

This is a simple, Excel-based tool for assessing and comparing costs of pneumococcal conjugate vaccine (PCV) vaccination programs with each PCV product available in the global market. It aims to help national-level policymakers specifically in countries eligible for support from Gavi, the Vaccine Alliance, compare products and estimate vaccination program costs for different PCVs, exploring up to four different vaccine options at a time.The tool calculates cold chain volume and costs annually and for a total period of five years. Cost estimates are composed of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery). Cost estimates are provided separately for the country perspective and the combined country and Gavi perspective.It is important to note that cost is only one consideration when selecting a PCV product, and users involved in decision-making around new vaccine introduction/switch or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages below. Please be sure to check out this seven-minute tutorial video, which is in English, with French and Spanish subtitled versions also available. If you have additional questions or need support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.NOTE: Please refer to this web page for the most up-to-date version of the calculator, which is periodically updated to reflect the evolving vaccine landscape.